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A trial fibrillation (AF) presents a serious health risk, but its mechanisms remain unclear because of the limited resolution, coverage, and surface-only recordings of multielectrode mapping. 1, 2 The advent of near-infrared optical mapping (NIOM) brought exciting opportunities for recording electrophysiological signals within the intramural heart wall in ex vivo animal studies and even bloodperfused hearts. 3 Further application of high-resolution transmural NIOM in ex vivo human atria has been able to resolve intramural conduction to a depth of a few millimeters within the 3-dimensional human atrial wall during AF and circumvent the limitations of surface-only multielectrode mapping, providing a better understanding of AF. 2, 4 Thus, in vivo NIOM may aid in defining patient-specific arrhythmia mechanisms, thereby potentially enhancing targeted treatment. However, NIOM has not been performed in large animal models in vivo, a necessary first step.
For the first time, in a canine model, this study successfully conducted in vivo high-resolution NIOM, integrated with a multielectrode array (MEA), to visualize atrial conduction during sinus rhythm (SR), atrial pacing, and AF. The canine right atrium (RA, n=1) was simultaneously mapped with NIOM and MEA in vivo, and subsequently ex vivo, in accordance with The Ohio State University Institutional Animal Care and Use Committee. In vivo NIOM was performed via a right-sided thoracotomy. Excitation lights (655±20 nm) and a high-resolution CMOS camera (complimentary metal oxide semiconductor; longpass emission filter 720 nm, 100×100 pixels, 0.32×0.32 mm 2 , MiCAM Ultima-L; SciMedia) were arranged around the thoracic window and focused on the lateral RA (Figure [A] ). A customized MEA (8×8 electrodes with 3 mm distance, Abbott), with a transparent flex circuit, was placed on the RA epicardial surface (Figure [A] ). Unipolar signals were acquired by an Ensite Velocity system (Abbott), and activation was marked at the point of maximum negative slope. An Octopus tissue stabilizer (Medtronic) was used to hold the MEA and decrease motion. A guidewire introduced via the right femoral artery guided a luminal catheter to the right coronary artery (Figure [A] ), and 10 mL of warm saline-diluted near-infrared voltage-sensitive dye (di-4-ANBDQBS, 1.5 mg in ethanol, University of Connecticut Health Center) was delivered during 20 s. No myocardial ischemia or acute cardiotoxic effects were observed after dye injection. Staining was repeated after 40 minutes to counter washout. Right vagal nerve stimulation (VNS), at 10 to 30 Hz for 10-20 s, was used to temporarily slow heart rate, produce atrioventricular block, and diminish contraction. In vivo NIOM and MEA recordings were taken during SR, 300 ms cycle length RA pacing, and sinoatrial node (SAN) recovery from pacing, with and without VNS, and during AF, which was induced by burst pacing at 130 ms cycle length during VNS. After in vivo NIOM, the same intact canine atria was mapped ex vivo with integrated NIOM and MEA. The data related to this study are available from the corresponding author on reasonable request as well as in the Data Supplement. In vivo optical action potentials (OAPs) showed a sharp upstroke that corresponded with atrial activation at a neighboring electrode (Figure [B] , left). When comparing subsequent ex vivo NIOM using an excitationcontraction blocker, blebbistatin (10 µM; Figure [B] , right), in vivo OAPs were affected by motion artifact ≈40 to 50 ms after OAP upstrokes, which compromised repolarization pattern analysis. However, analyzing the OAP derivative (dV/dt max ) within the premotion time frame reliably reproduced the activation conduction pattern seen simultaneously by MEA (Figure [C] ) and later ex vivo (Figures I-III in the Data Supplement). During SR at baseline (124±11 beats per minute) and during VNS (59±9 beats per minute), integration of NIOM and MEA revealed atrial activation originating from the SAN region (Figures [C] , right). RA pacing led to a retrograde conduction pattern that propagated anisotropically around the intramural SAN-septal block zone, as previously described 5 ( Figure [C] , left). The accuracy and reproducibility of in vivo NIOM are further supported by beat to beat consistency of conduction pattern and timing, including the earliest atrial activation sites (exit points from SAN) during SR at baseline and after 0.2 µM acetylcholine perfusion, used as an ex vivo surrogate for VNS (Figures I and II in the Data Supplement). Intramural SAN-septal block zone was also seen consistently by NIOM (Figure [C] ), which was obscured on canine endo-epicardial MEA. 1 During in vivo AF episodes, the atrial contractioninduced motion artifact was decreased, and OAP upstrokes could be reliably analyzed between ventricular contractions. Thus, NIOM was able to show reentrant activation around the SAN region as previously seen in canine, 5 whereas MEA showed an incomplete portion of the same reentrant circuit because of its smaller coverage (Figure [D] ). Importantly, ex vivo AF had a similar RA activation pattern ( Figure III in the Data Supplement). Future studies to further develop this novel methodology should focus on minimizing the influence of motion artifact and validation in structurally remodeled hearts, where fibrosis and fat infiltration may affect OAP quality.
In conclusion, this study, for the first time, provides evidence of successful in vivo application of high-resolution NIOM to directly visualize detailed atrial conduction patterns during SR, atrial pacing, and AF. Thus, this study opens the door to a promising potential application of the NIOM method to overcome the limitations of clinical surface electrode mapping and resolve patientspecific arrhythmia mechanisms to improve treatment.
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